
- •MicroRna (miRna)
- •Splicing
- •Editing
- •Polyadenylation
- •Transport
- •A hairpin loop from a pre-mRna. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue).
- •Three-dimensional representation of the 50s ribosomal subunit. Rna is in ochre, protein in blue. The active site is in the middle (red). Translation
- •Inside the ribosome
- •Prokaryotes vs. Eukaryotes
- •Key discoveries in rna biology
- •TRna Function: Synthetases
- •Accuracy & Proofreading
The "life cycle" of an mRNA in a eukaryotic cell. RNA istranscribed in the nucleus; processed, it is transported to thecytoplasm and translated by the ribosome. At the end of its life, the mRNA is degraded
MicroRna (miRna)
Main article: microRNA
MicroRNAs (miRNAs) are small RNAs that typically are partially complementary to sequences in metazoan messenger RNAs.[16] Binding of a miRNA to a message can repress translation of that message and accelerate poly(A) tail removal, thereby hastening mRNA degradation. The mechanism of action of miRNAs is the subject of active research.[17]
MicroRNAs are produced from either their own genes or from introns.
In metazoans, small interfering RNAs (siRNAs) processed by Dicer are incorporated into a complex known as the RNA-induced silencing complex or RISC. This complex contains an endonuclease that cleaves perfectly complementary messages to which the siRNA binds. The resulting mRNA fragments are then destroyed by exonucleases. siRNA is commonly used in laboratories to block the function of genes in cell culture. It is thought to be part of the innate immune system as a defense against double-stranded RNA viruses.[15]
Mediating RNA interference in cultured mammalian cells.
siRNAs have a well-defined structure: a short (usually 21-nt) double-strand RNA (dsRNA) with 2-nt 3' overhangs on either end:
Each strand has a 5' phosphate group and a 3' hydroxyl (-OH) group. This structure is the result of processing by dicer, an enzyme that converts either long dsRNAs or small hairpin RNAs into siRNAs.[3] siRNAs can also be exogenously (artificially) introduced into cells by various transfection methods to bring about the specific knockdown of a gene of interest. In essence, any gene whose sequence is known can, thus, be targeted based on sequence complementarity with an appropriately tailored siRNA. This has made siRNAs an important tool for gene function and drug target validation studies in the post-genomic era.
Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA molecules, 20-25 nucleotides in length, that play a variety of roles in biology. The most notable role of siRNA is its involvement in the RNA interference (RNAi) pathway, where it interferes with the expression of a specific gene. In addition to its role in the RNAi pathway, siRNA also acts in RNAi-related pathways, e.g., as an antiviral mechanism or in shaping the chromatin structure of a genome; the complexity of these pathways is only now being elucidated.
siRNAs were first discovered by David Baulcombe's group at the Sainsbury Laboratory in Norwich, England, as part of post-transcriptional gene silencing (PTGS) in plants. The group published their findings in Science in a 1999 paper titled "A species of small antisense RNA in posttranscriptional gene silencing in plants".[1] Shortly thereafter, in 2001, synthetic siRNAs were shown to be able to induce RNAi in mammalian cells by Thomas Tuschl, and colleagues in a paper published in Nature.[2] This discovery led to a surge in interest in harnessing RNAi for biomedical research and drug development.
5' cap structure
The 5' cap has 4 main functions:
Regulation of nuclear export.
Prevention of degradation by exonucleases.
Promotion of translation (see ribosome and translation).
Promotion of 5' proximal intron excision.
Nuclear export of RNA is regulated by the Cap binding complex (CBC), which binds exclusively to capped RNA. The CBC is then recognized by the nuclear pore complex and exported. Once in the cytoplasm after the pioneer round of translation, the CBC is replaced by the translation factors eIF-4E and eIF-4G. This complex is then recognized by other translation initiation machinery including the ribosome.[1]
Cap prevents 5' degradation in two ways. First, degradation of the mRNA by 5' exonucleases is prevented (as mentioned above) by functionally looking like a 3' end. Second, the CBC complex and the eIF-4E/eIF-4G block the access of decapping enzymes to the cap. This increases the half-life of the mRNA, essential in eukaryotes as the export process takes significant time.
Decapping of an mRNA is catalyzed by the decapping complex made up of at least Dcp1 and Dcp2, which must compete with eIF-4E to bind the cap. Thus the 5' cap is a marker of an actively translating mRNA and is used by cells to regulate mRNA half-lives in response to new stimuli. Undesirable mRNAs are sent to P-bodies for temporary storage or decapping, the details of which are still being resolved.[2]
The mechanism of 5' proximal intron excision promotion is not well understood, but the 5' cap appears to loop around and interact with the spliceosome in the splicing process, promoting intron excision.